Get AI Briefings, Transcripts & Alerts on Local & National Government Meetings — Forever.
NCI SBIR investor initiative and grants: what founders should know
Loading...
Summary
NCI SBIR’s investor initiative brings reviewers and investors to its portfolio and provides sponsored presentation opportunities; the program and Phase 2 awards can extend runway and validate technology for later fundraising.
During the Innovation Lab episode, Billy Baza described concrete NCI SBIR resources intended to help portfolio companies connect with investors and prepare for commercialization.
Baza said NCI SBIR invites roughly 80 members of its investor network each year to review the portfolio and provide feedback. Selected companies may receive sponsored presentation slots at two industry events and payment of presentation fees to support networking. "Once you become in our portfolio, we're constantly spreading that information to our network," Baza said.
The podcast also noted the practical scale of SBIR Phase 2 funding: "Our Phase 2 award is a $2,250,000 award," Baza said, explaining that Phase 2 can support early clinical work or experiments to derisk programs for investors. The panel encouraged applicants to resubmit after receiving constructive peer review feedback, noting that resubmissions have higher success metrics.
Baza closed by directing listeners to sbir.cancer.gov for funding opportunities and commercialization resources and offering the NCI inquiry email and phone number for further help.
These NCI SBIR supports are intended to help small biotech firms extend runway, demonstrate milestones to investors, and prepare commercialization plans.
